Acute Hemolytic Transfusion Reactions (immune) - Further Reading

Note: Canadian Blood Services offers no endorsement of and assumes no liability for the currency, accuracy, or availability of any information on these sites.

1. Beauregard P, Blajchman MA. Hemolytic and pseudo-hemolytic transfusion reactions: an overview of the hemolytic transfusion reactions and the clinical conditions that mimic them. Transfus Med Rev 1994 Jul;8(3):184-99.  
2. Callum, JL, Kaplan, HS, Merkley, L L, Pinkerton, PH, Rabin Fastman, B, Romans, RA. Reporting of near-miss events for transfusion medicine: improving transfusion safety. Transfusion 2001; 41: 1204-11. [ Full text ] [ Medline ]
3. Capon SM, Goldfinger D. Acute hemolytic transfusion reaction, a paradigm of the systemic inflammatory response: new insights into pathophysiology and treatment. Transfusion 1995;35(6):513-20.
4. Davenport RD. Hemolytic transfusion reactions. In: Popovsky MA, ed. Transfusion reactions, 2nd ed. Bethesda, MD: AABB Press;2001. p.2-36.
5. Davenport RD. The role of cytokines in haemolytic transfusion reactions. Immunol Invest. 1995 Jan-Feb;24 (1-2): 319-31. [Medline]
6. Fitzpatrick T, Fitzpatrick L. Nursing management of transfusion reactions. In: Popovsky M, editor. Transfusion reactions, 2nd ed. Arlington, VA: AABB Press;2001. p.417-48.
7. Kaplan H. Lessons learned (editorial). Transfusion 2001;41(5): 575-6. [ Full text ]
8. Kleinman S, Chan P, Robillard P. Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev 2003; 17(2):120-162.
9. Larsson LG, Welsh VJ, Ladd DJ. Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion 2000 Aug;40(8): 902 -6. [Full text ] [ Medline ]
10. Linden JV, Wagner K, Voytovich AE, Sheehan J. Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion 2000;40(10):1207-13. [ Full text ] [ Medline ]
11. Park TS, Kim KU, Jeong WJ, Kim HH, Chang CL, Chung JS, Cho GJ, Lee EY, Son HC. Acute haemolytic transfusion reactions due to multiple alloantibodies including anti-E, anti-c and anti Jkb. J Korean Med Sci. 2003 Dec; 18(6): 894-6. [Medline]
12. Robillard P, Nawef KL, Jochem K. The Quebec hemovigilance system: description and results from the first years. Transfus Apheresis Sci. 2004 Oct; 31(2): 111-22. [Medline]
13. Sazama K, JD, DeChristopher PJ,Dodd R, Harrison CR, Shulman IA, Cooper ES, et al. Practice parameter for the recognition, management, and prevention of adverse consequences of blood transfusion. Arch Pathol Lab Med 2000 ;124(1): 61–70.
14. Stroncek D, Procter JL, Johnson J. Drug-induced hemolysis: cefotetan-dependent haemolytic anemia mimic an acute intravascular immune transfusion reaction. Am J Hematol. 2000 May; 64(1): 67-70. [Medline]
15. Telen M.J. Principles and problems of transfusion in sickle cell disease. Semin Hematol. 2001;38:315-23. [ Medline ].
16. Whitsett, CF, Robichaux, MG. Assessment of blood administration procedures:problems identified by direct observationand administrative incident reporting. Transfusion 2001; 41: 581-6. [ Full text ] [ Medline ]
17. Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB, et al. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. Br Med J 1999; 319:16-9.
18. Win N, Doughty H, Telfer P, Wild BJ, Pearson TC. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion 2001 Mar; 41(3)323-8. [ Full text ] [Medline]